Home › Attention Deficit Hyperactivity Disorder › Georgia › Atlanta
Attention Deficit Hyperactivity Disorder clinical trials in Atlanta, GA
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Advanced Discovery Research LLC, Atlanta
- Clinical Integrative Research Center of Atlanta, Atlanta
- CenExcel iResearch, LLC, Decatur · 6 mi away
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Atlanta
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Atlanta
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Emory University (Children's Healthcare of Atlanta), Atlanta
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Pittsburgh, PA5 studies
- Washington, DC5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- Los Angeles, CA4 studies
- Baltimore, MD4 studies
- New York City, NY4 studies
- Durham, NC4 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.